188 related articles for article (PubMed ID: 2561500)
1. Suppression of testicular activity by a GnRH agonist in hypophysectomized, gonadotropin-treated mice.
Iwasaki K; Fujii A; Arimura A; Groot K
Tokai J Exp Clin Med; 1989 Mar; 14(1):25-8. PubMed ID: 2561500
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone and its agonist inhibit testicular luteinizing hormone receptor and steroidogenesis in immature and adult hypophysectomized rats.
Bambino TH; Schreiber JR; Hsueh AJ
Endocrinology; 1980 Oct; 107(4):908-17. PubMed ID: 6250797
[TBL] [Abstract][Full Text] [Related]
3. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
4. Effects of gonadotropin-releasing hormone receptor blockade on rat testicular gonadotropin and lactogen receptors, steroidogenesis, and responses to human chorionic gonadotropin stimulation.
Huhtaniemi IT; Catt KJ
Endocrinology; 1985 Jan; 116(1):281-7. PubMed ID: 2981066
[TBL] [Abstract][Full Text] [Related]
5. Factors determining whether the direct effects of an LHRH agonist on Leydig cell function in vivo are stimulatory or inhibitory.
Sharpe RM; Doogan DG; Cooper I
Mol Cell Endocrinol; 1983 Sep; 32(1):57-71. PubMed ID: 6354775
[TBL] [Abstract][Full Text] [Related]
6. Proopiomelanocortin-derived peptides in testicular interstitial fluid: characterization and changes in secretion after human chorionic gonadotropin or luteinizing hormone-releasing hormone analog treatment.
Valenca MM; Negro-Vilar A
Endocrinology; 1986 Jan; 118(1):32-7. PubMed ID: 3000742
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of pituitary-gonadal function in male rats by a potent GnRH antagonist.
Puente M; Catt KJ
J Steroid Biochem; 1986 Dec; 25(6):917-25. PubMed ID: 3025519
[TBL] [Abstract][Full Text] [Related]
8. Differential actions of gonadotropin-releasing hormone and human chorionic gonadotropin on interstitial fluid volume and immunoglobulin G concentrations in adult rat testis.
Hedger MP; Muir JA
J Androl; 2000; 21(5):747-52. PubMed ID: 10975422
[TBL] [Abstract][Full Text] [Related]
9. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.
Pogach LM; Lee Y; Gould S; Giglio W; Huang HF
Cancer Res; 1988 Aug; 48(15):4354-60. PubMed ID: 3134124
[TBL] [Abstract][Full Text] [Related]
10. Absence of testicular protection by a gonadotropin-releasing hormone analogue against cyclophosphamide-induced testicular cytotoxicity in the mouse.
da Cunha MF; Meistrich ML; Nader S
Cancer Res; 1987 Feb; 47(4):1093-7. PubMed ID: 3542201
[TBL] [Abstract][Full Text] [Related]
11. Sites of paradoxical action of the LHRH agonist (D-Trp6)-LHRH.
Arimura A; Talbot S; Serafini PC; Schally AV
Int J Fertil; 1980; 25(3):151-6. PubMed ID: 6108923
[TBL] [Abstract][Full Text] [Related]
12. Mice are insensitive to the antitesticular effects of luteinizing hormone-releasing hormone agonists.
Wang NG; Sundaram K; Pavlou S; Rivier J; Vale W; Bardin CW
Endocrinology; 1983 Jan; 112(1):331-5. PubMed ID: 6291919
[TBL] [Abstract][Full Text] [Related]
13. Effects of gonadotropin-releasing hormone variants on plasma and testicular androgen levels in intact and hypophysectomized male frogs, Rana esculenta.
D'Antonio M; Fasano S; de Leeuw R; Pierantoni R
J Exp Zool; 1992 Jan; 261(1):34-9. PubMed ID: 1729384
[TBL] [Abstract][Full Text] [Related]
14. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
[TBL] [Abstract][Full Text] [Related]
15. Absence of a direct inhibitory effect of the gonadotropin-releasing hormone (GnRH) agonist D-Ser (TBU)6, des-Gly-NH2(10) GnRH ethylamide (Buserelin) on testicular steroidogenesis in men.
Schaison G; Brailly S; Vuagnat P; Bouchard P; Milgrom E
J Clin Endocrinol Metab; 1984 May; 58(5):885-8. PubMed ID: 6423662
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone agonist analog-induced steroidogenic lesion in the neonatal rat testis: evidence for direct gonadal action.
Huhtaniemi IT; Clayton RN; Catt KJ
Endocrinology; 1984 Jul; 115(1):233-8. PubMed ID: 6329649
[TBL] [Abstract][Full Text] [Related]
17. Hormonal control of apoptotic cell death in the testis: gonadotropins and androgens as testicular cell survival factors.
Tapanainen JS; Tilly JL; Vihko KK; Hsueh AJ
Mol Endocrinol; 1993 May; 7(5):643-50. PubMed ID: 8316250
[TBL] [Abstract][Full Text] [Related]
18. Testicular function after local injection of 6-hydroxydopamine or norepinephrine in the golden hamster (Mesocricetus auratus).
Mayerhofer A; Amador AG; Steger RW; Bartke A
J Androl; 1990; 11(3):301-11. PubMed ID: 2117002
[TBL] [Abstract][Full Text] [Related]
19. Effects of 3-methyl-4-nitrophenol in diesel exhaust particles on the regulation of testicular function in immature male rats.
Li C; Taneda S; Suzuki AK; Furuta C; Watanabe G; Taya K
J Androl; 2007; 28(2):252-8. PubMed ID: 17021341
[TBL] [Abstract][Full Text] [Related]
20. Effects of an LHRH agonist and gonadotropins on testicular prolactin receptors.
Fishback JB; Arimura A; Turkelson CM
Peptides; 1982; 3(5):845-50. PubMed ID: 6294638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
